Market Overview

The Medicines Company, Alnylam Announce Global Alliance

Related MDCO
The Medicines Company Surges Amid Credit Suisse Upgrade
US Stock Futures Surge Ahead Of Earnings, ADP Data

The
Medicines Company (NASDAQ: MDCO) and Alnylam
Pharmaceuticals (NASDAQ: ALNY) announced today that they have formed
an exclusive global alliance for the development and commercialization
of Alnylam's ALN-PCS RNAi therapeutic program for the treatment of
hypercholesterolemia.

“This new alliance unites two organizations with a shared culture and
commitment to innovation. In my view and past experience, there could be
no stronger partner for our ALN-PCS program than The Medicines Company,
which has demonstrated industry-wide leadership in the advancement of
cardiovascular medicines to patients and remarkable success in its
strategy of in-licensing, developing, and commercializing breakthrough

See full press release

Posted-In: Earnings News Guidance Contracts Management

 

Related Articles (ALNY + MDCO)

Around the Web, We're Loving...

Get Benzinga's Newsletters